Reply to Jain: High Circulating Plasma Soluble Receptor for Advanced Glycation End-Products in Early COVID-19-associated Acute Respiratory Distress Syndrome: Pathophysiological Significance?

Am J Respir Crit Care Med. 2022 Jan 15;205(2):256-257. doi: 10.1164/rccm.202108-1969LE.

Authors

Guillaume Dumas¹, Natacha Kapandji¹, Elie Azoulay¹, Jean-Michel Constantin^{2

3}

Affiliations

¹ Hôpital Saint-Louis Paris, France.
² Sorbonne University Paris, France.
³ Hopital de la Pitié Salpétrière Paris, France.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Glycation End Products, Advanced
Humans
Receptor for Advanced Glycation End Products
Respiratory Distress Syndrome*
SARS-CoV-2

Substances

Glycation End Products, Advanced
Receptor for Advanced Glycation End Products